Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Elite Traders Group Offers Insights on Biotech Industry Comparing It to the Next Computer Age
The Following Is an Investment Opinion Being Issued by the Elite Traders Group LLC

NEW YORK, NY -- (Marketwire) -- 01/14/13 -- Insights on the Following Companies: International Stem Cell Corporation, Kraig Biocraft Laboratories, Inc. ScripsAmerica, Inc., Celsion Corp.

Biotech researchers across the world are experiencing a renaissance in their industry. Like the massive growth experienced by technology companies of the 90s, the biotech industry is prepped and ready to realize the same growth. Technology has provided new ways to research treatments, therapies and distribute new drugs. Many small biotech companies have taken advantage of this new technology and are the source of these new drugs. With many patents expiring in 2012, the large corporations are beginning to acquire these smaller companies in an effort to attain new patents.

With new discoveries every day in the biotech industry the shelf life of a new drug is becoming shorter. According to information gathered by Bloomberg, 676 biotech takeovers occurred in rising numbers over the last 3 years. Expect this trend to continue over the next 3 years, as more patents will expire and new drugs will be discovered at an increasingly higher rate.

Researchers have just started to scratch the surface in this young and exciting field. 2012 revealed many advances in the Anti-obesity, Myelofibrosis, cancer, HCV, RA, MS, psoriasis, HCC, and dyslipidemia fields. 2013 promises to discover new treatments for viruses, targeted cancer treatments, Alzheimer's, antivirals and orphan diseases. In addition, many oral therapies are being researched in the areas of RA, Psoriasis, and MS. Stem cell research will also be represented well in 2013.

Investors continue to be unafraid of the lengthy and difficult process to achieve FDA approval. In fact, many have plans to increase the M&A budgets. Many small biotech companies are also seeing the oncoming wave of advancements in this field and have decided to take on the challenge of doing their own marketing. The rewards well outweigh the risks for these small biotech companies.

The biotech industry has many up and coming companies that are worth taking a closer look.

International Stem Cell Corporation (OTCQB: ISCO) is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). http://www.firstpennypicks.com/get-your-free-research-report/

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development of high performance polymers. Kraig works in cooperation with leading universities in the fields of genetics and genetic engineering to develop new recombinant fibers and materials which the company believes will have broad commercial applications. http://www.firstpennypicks.com/get-your-free-research-report/

ScripsAmerica, Inc. (OTCQB: SCRC) delivers pharmaceutical products to a wide range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies through the largest pharmaceutical distributor in North America, McKesson Corporation. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, Curtis Pharmaceuticals, MedVet and the United States Veterans Administration. http://www.firstpennypicks.com/get-your-free-research-report/

Celsion Corp. (NASDAQ: CLSN) is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, the Kyungpook National University Hospital and the Beijing Cancer Hospital. http://www.firstpennypicks.com/get-your-free-research-report/

To Receive More Reports like this one Subscribe free at http://www.FirstPennyPicks.com

VIP Group

Increase Your Day Trading Profits by joining our VIP Pre-promotion/Early Alert Membership For only $29.95/month or $295/year: http://www.firstpennypicks.com/vip-membership/

http://www.Firstpennypicks.com was developed as a beacon of hope in the micro-cap stock newsletter industry. We always hand-pick our alerts as opposed to biased advertising. This is why we are the fastest growing community of micro-cap traders on the web.

Please note that all media from Elite Traders Group LLC and FirstPennyPicks.com is investment opinion only. Elite Traders Group employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This advertisement is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the profiled companies listed here.

FULL DISCLAIMER http://www.firstpennypicks.com/disclaimer/

Contact:
Elite Traders Group LLC
Email Contact

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest AJAXWorld RIA Stories
All major researchers estimate there will be tens of billions devices – computers, smartphones, tablets, and sensors – connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. With major technology companies and startups ...
SYS-CON Events announces a new pavilion on the Cloud Expo floor where WebRTC converges with the Internet of Things. Pavilion will showcase WebRTC and the Internet of Things. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation ...
DevOps, Cloud and Your SDLC Cloud computing started a technology revolution; now DevOps is driving that revolution forward. By enabling new approaches to service delivery, cloud and DevOps together are delivering even greater speed, agility, and efficiency. No wonder leading i...
Enthusiasm for the Internet of Things has reached an all-time high. In 2013 alone, venture capitalists spent more than $1 billion dollars investing in the IoT space. With “smart” appliances and devices, IoT covers wearable smart devices, cloud services to hardware companies. Nest...
Are you developing or hosting PHP applications? Are you doing performance sanity checks along your delivery pipeline? No? Not Yet? Then start with a quick check. It only takes 15 minutes and it really pays off. As a developer you can improve your code, and as somebody responsible...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021


SYS-CON Featured Whitepapers
ADS BY GOOGLE